| 1.8 |
5.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.1 |
3.4 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.0 |
4.9 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.8 |
4.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.7 |
2.2 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.7 |
2.1 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.7 |
4.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.6 |
1.7 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.5 |
1.5 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.5 |
2.9 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.5 |
2.3 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.4 |
1.9 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.4 |
1.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.4 |
1.4 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.3 |
1.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.3 |
1.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.3 |
1.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.2 |
1.4 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 |
2.9 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.2 |
1.8 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.2 |
0.6 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.2 |
0.9 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.2 |
0.8 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 0.2 |
2.7 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.2 |
0.7 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
1.3 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
3.9 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
1.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.7 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.1 |
1.4 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
1.0 |
GO:0033147 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.3 |
GO:1904956 |
regulation of endodermal cell fate specification(GO:0042663) motor learning(GO:0061743) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.1 |
0.6 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.4 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.4 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
0.9 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
1.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.3 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.1 |
2.2 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.1 |
0.6 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.1 |
1.1 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.1 |
0.6 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
1.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.7 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
1.5 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.6 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
1.0 |
GO:0070232 |
regulation of T cell apoptotic process(GO:0070232) |
| 0.0 |
0.9 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.2 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
1.5 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
1.9 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.8 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.5 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
0.6 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
1.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
2.5 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
1.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.6 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:1902369 |
negative regulation of RNA catabolic process(GO:1902369) |
| 0.0 |
0.4 |
GO:0006414 |
translational elongation(GO:0006414) |
